Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist designed to bind to GLP-1 receptors, which help regulate appetite.[4] Semaglutide was originally developed as a treatment for T2D to improve blood sugar levels, but clinical trials later showed that patients also lost weight while taking it.[4-8] Additional studies support semaglutides effectiveness in promoting weight loss in non-diabetics.[5,8,11] Semaglutide supports weight loss by suppressing appetite, delaying stomach emptying, and stimulating insulin secretion.[4] It is typically used alongside dietary changes and exercise in adults with and without diabetes.[4] All GLP-1 medications require a prescription from a healthcare provider
The most common adverse effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort
These hormones work to regulate appetite and enhance blood sugar control, making it easier to stay on track with your weight management plan
Tirzepatide is another GLP-1 agonist but also mimics glucose-dependent insulinotropic polypeptide (GIP), which releases more insulin in the bloodstream and effectively lowers blood sugar levels